Beta‐Blockers After Myocardial Infarction With Preserved and Mildly Reduced Ejection Fraction: A Meta‐Analysis With Trial Sequential Analysis
European Journal of Clinical Investigation · 2026-06 · 56 (6)
DOI: 10.1111/eci.70238 ↗Kurz gefasst
Metaanalyse in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 17.06.2026. Verfasst von Michele Maremmani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Sant'Andrea Hospital, La Spezia, Italy. Hauptthemen laut MEDLINE: Adrenergic beta-Antagonists, Myocardial Infarction, Stroke Volume. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Aims
We aimed to evaluate the efficacy of β‐blockers after myocardial infarction (MI) across left ventricular ejection fraction (LVEF) strata and to assess the conclusiveness of the available evidence using trial sequential analysis (TSA).
Methods
PubMed, Embase and ClinicalTrials.gov were searched for randomized controlled trials (RCTs) evaluating β‐blockers in post‐MI patients with LVEF ≥ 40%. A time‐to‐event meta‐analysis was performed for the primary composite (as defined by each trial) and for individual endpoints. The Mantel–Haenszel method was used to pool risk ratios (RR) for major adverse cardiovascular events (MACE; death, MI or heart failure), including LVEF‐stratified analyses. TSA estimated the required information size (RIS) and generated adjusted significance and futility boundaries, assuming a 5% type I error and 90% power.
Results
Across 19,826 post‐MI patients (17,941 with LVEF ≥ 50% and 1885 with LVEF 40%–49%), β‐blockers did not reduce time to the primary endpoint (HR 0.92, 95% CI 0.85–1.01; p = 0.08; I 2 = 35%) or mortality. In patients with preserved LVEF (≥ 50%), β‐blocker therapy did not reduce the risk of death or MACE (RR 0.96, 95% CI 0.87–1.05; I 2 = 42%), with TSA confirming futility. Among those with mildly reduced LVEF (40%–49%), β‐blockers reduced MACE (RR 0.74, 95% CI 0.58–0.94; I 2 = 0%), although TSA failed to establish conclusiveness (RIS of 5717 [14.4%]). A significant interaction by LVEF subgroup was observed for cardiac death ( p = 0.03). Conclusions β‐blockers conferred no benefit in post‐MI patients with preserved LVEF, with conclusive evidence of futility, whereas therapy was associated with reduced MACE in those with mildly reduced LVEF, pending confirmation in further adequately powered randomized trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Sant'Andrea Hospital, La Spezia, Italy.
- Department of Cardiology, Vita-Salute San Raffaele University, Milan, Italy.
- Department of Internal Medicine B, University of Medicine Greifswald, Greifswald, Germany.
- Center for Molecular Cardiology, Schlieren Campus, University of Zurich, Zurich, Switzerland.
- Department of Internal Medicine, University of Genoa, Genoa, Italy.
- IRCCS Ospedale Policlinico San Martino Genoa - Italian Cardiovascular Network, Genoa, Italy.
ORCID-Profile: Fabrizio Montecucco, Victor Schweiger
Zitieren
APA
Maremmani, M., Gianfico, P., Templin, C., Montecucco, F., Liberale, L., Kraler, S., Schweiger, V., Berti, S., Emdin, M., & Di Vece, D. (2026). Beta‐Blockers After Myocardial Infarction With Preserved and Mildly Reduced Ejection Fraction: A Meta‐Analysis With Trial Sequential Analysis. European Journal of Clinical Investigation, 56(6). https://doi.org/10.1111/eci.70238
Vancouver
Maremmani M, Gianfico P, Templin C, Montecucco F, Liberale L, Kraler S, et al. Beta‐Blockers After Myocardial Infarction With Preserved and Mildly Reduced Ejection Fraction: A Meta‐Analysis With Trial Sequential Analysis. European Journal of Clinical Investigation. 2026;56(6). doi:10.1111/eci.70238
BibTeX
@article{Maremmani2026,
author = {Maremmani, Michele and Gianfico, Paolo and Templin, Christian and Montecucco, Fabrizio and Liberale, Luca and Kraler, Simon and Schweiger, Victor and Berti, Sergio and Emdin, Michele and Di Vece, Davide},
title = {Beta‐Blockers After Myocardial Infarction With Preserved and Mildly Reduced Ejection Fraction: A Meta‐Analysis With Trial Sequential Analysis},
journal = {European Journal of Clinical Investigation},
year = {2026},
volume = {56},
number = {6},
doi = {10.1111/eci.70238}
}
EUVIMED